FUSN - Fusion Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $20.33. This is a potential upside of $-1.22 (-5.66%) from yesterday's end of day stock price of $21.55.

Fusion Pharmaceuticals 's activity chart (see below) currently has 32 price targets and 28 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.13% with an average time for these price targets to be met of 241.63 days.

Most recent stock forecast was given by YUAN ZHI from B. RILEY on 20-Mar-2024. First documented stock forecast 21-Jul-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Dec-2022

$13

$-8.55 (-39.68%)

$13

2 years 21 days ago
(20-Mar-2024)

3/4 (75%)

$-8.09 (-38.36%)

287

Buy Since 04-Mar-2024

$16

$-5.55 (-25.75%)

$16

2 years 21 days ago
(20-Mar-2024)

1/2 (50%)

$-5.09 (-24.13%)

15

Hold Since 19-Mar-2024

$10

$-11.55 (-53.60%)

2 years 22 days ago
(19-Mar-2024)

0/1 (0%)

$-11.18 (-52.79%)

Buy Since 21-Jul-2020

$10

2 years 22 days ago
(19-Mar-2024)

5/6 (83.33%)

$6.75 (207.69%)

861

Buy Since 16-Sep-2022

$11

$-10.55 (-48.96%)

2 years 22 days ago
(19-Mar-2024)

1/2 (50%)

$-10.18 (-48.06%)

496

Show more analysts

Please expand the browser size to see the chart

What is FUSN (Fusion Pharmaceuticals ) average time for price targets to be met?

On average it took 241.63 days on average for the stock forecasts to be realized with a an average price target met ratio 53.13

Which analyst has the current highest performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

MATTHEW HARRISON

Which analyst has the current lower performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

SUJI JEONG

Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals )?

Matthew Harrison works at MORGAN STANLEY and has 8 price targets and 9 ratings on FUSN

Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals )?

John Walsh with highest potential upside - $0

Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals )?

Suji Jeong with lowest potential downside - -$11.55

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?